Chemspace and LabNetwork collaborate to extend access to chemical databasesFebruary 13, 19
Collaboration provides drug discovery researchers access to European distribution and local support for library of in-stock and on-demand compounds
Riga, Latvia and Shanghai, China, February 13 2019: Chemspace and LabNetwork, a WuXi AppTec company, both online marketplaces for chemical compounds used in drug discovery, today announced they have entered into a collaboration agreement. Under the agreement, LabNetwork’s products will be available on www.chem-space.com, with distribution and technical support provided by Chemspace for European customers. The collaboration expands the market reach of both companies to pharma and biotech companies.
The Chemspace database encompasses over 100 million unique chemical building blocks, fragments and screening compounds, and is the world’s largest library of purchasable chemicals. The online catalogue includes in-stock and make-on-demand molecules, offering an easy, fast way to search using a broad range of filter options, such as substructure, similarity, and by using various text identifiers.
Use of the Chemspace database is free-of-charge for customers. There are no license fees for users to review and access the platform. Chemspace invites global chemistry suppliers, ranging from small to large organizations, to upload their catalogues to the site, to provide an efficient solution for buyers when sourcing chemicals.
Dr Yurii Moroz, CEO at Chemspace, commented: “The collaboration with LabNetwork will provide drug discovery scientists, medicinal chemists, and academic researchers access to a vast diversity of high-quality products. We see a lot of synergy in our companies combining forces both from a business perspective and also to improve availability of compounds to the research community. Ultimately to shorten the drug discovery process in the hope of finding better cures for patients, quicker.”
This entry was posted in News from Zyme and the companies we work with. Bookmark the permalink.